Document:

Exhibit
4.6

 

THE
REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE OPTION
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTION AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE OPTION OR CAUSE IT TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT
WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THE PURCHASE OPTION BY ANY PERSON FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FROM
THE COMMENCEMENT OF SALES IN THE OFFERING TO ANYONE OTHER THAN TO (I) CHARDAN CAPITAL MARKETS, LLC (“CHARDAN”)
OR AN UNDERWRITER OR SELECTED DEALER PARTICIPATING IN THE OFFERING OR (II) AN OFFICER OR PARTNER OF CHARDAN OR OF ANY SUCH UNDERWRITER
OR SELECTED DEALER AND IN ACCORDANCE WITH FINRA RULE 5110(E)(2).

 

THIS
PURCHASE OPTION IS NOT EXERCISABLE PRIOR TO THE CONSUMMATION BY ALPHATIME ACQUISITION CORP (THE “COMPANY”)
OF A MERGER, SHARE EXCHANGE, ASSET ACQUISITION, SHARE PURCHASE, REORGANIZATION OR SIMILAR BUSINESS COMBINATION (THE “BUSINESS
COMBINATION”) (AS DESCRIBED MORE FULLY IN THE COMPANY’S REGISTRATION STATEMENT (AS DEFINED HEREIN), AND VOID AFTER
5:00 P.M. NEW YORK CITY LOCAL TIME, ON THE EARLIER OF THE EXPIRATION DATE (AS DEFINED HEREIN) OR THE DAY IMMEDIATELY PRIOR TO THE DAY
ON WHICH THE COMPANY AND ALL OF ITS SUCCESSORS HAVE BEEN DISSOLVED.

 

UNIT
PURCHASE OPTION

FOR THE PURCHASE OF

UP TO 68,000 UNITS

OF

ALPHATIME ACQUISITION CORP

 

1.
PURCHASE OPTION.

 

THIS
CERTIFIES THAT, in consideration of $100.00 duly paid by or on behalf of Chardan Capital Markets, LLC (the “Holder”),
as registered owner of this Purchase Option, to AlphaTime Acquisition Corp (the “Company”), Holder is entitled,
at any time or from time to time upon the consummation by the Company of a Business Combination (the “Commencement Date”),
until, at or before 5:00 p.m., New York City local time, on the earlier of the five year anniversary of the effective date of the Registration
Statement and the day immediately prior to the day on which the Company and all of its successors have been dissolved, but not thereafter
(the “Expiration Date”), as described in the Company’s registration statement (the “Registration
Statement”) pursuant to which Units are offered for sale to the public in the Company’s initial public offering (the
“Offering”), to subscribe for, purchase and receive, in whole or in part, up to sixty eight thousand (68,000)
units (“Units”) of the Company, each Unit consisting of one (1) ordinary share, par value $0.0001 per share,
of the Company (“Shares”), one redeemable (1) warrant (“Warrants”), each Warrant
entitling the holder thereof to purchase one Share and one (1) right (“Rights”), each right entitling the holder
thereof to purchase one-tenth (1/10) of one Share. Each Warrant has the same terms as the warrants included in the Units being registered
for sale to the public by way of the Registration Statement (the “Public Warrants”), except as set forth herein.
Each Right has the same terms as the rights included in the Units being registered for sale to the public by way of Registration Statement
(the “Public Rights”), except as set forth herein. Notwithstanding anything to the contrary, the original Holder
of this Purchase Option agrees that it will not be permitted to exercise this Purchase Option after the five-year anniversary of the
commencement of sales of the Offering. During the period ending on the Expiration Date, the Company agrees not to take any action that
would terminate the Purchase Option. This Purchase Option is initially exercisable at $11.50 per Unit so purchased; provided,
however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase
Option, including the exercise price per Unit and the number of Units (and Shares, Warrants and Rights) to be received
upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial
exercise price or the adjusted exercise price, depending on the context.

 

    	 

     

    

 

2.
EXERCISE OF PURCHASE OPTION

 

2.1
Exercise Form. In order to exercise this Purchase Option, the exercise form attached hereto must be duly executed and completed
and delivered to the Company, together with this Purchase Option and payment of the Exercise Price for the Units being purchased payable
in cash or by certified check or official bank check or pursuant to Section 2.3 hereof. If the Purchase Option represented hereby
shall not be exercised at or before 5:00 p.m., New York City local time, on the Expiration Date, this Purchase Option shall become and
be void without further force or effect, and all rights represented hereby shall cease and expire.

 

2.2
Legend. Each certificate for the securities purchased under this Purchase Option shall bear a legend as follows, unless such securities
have been registered under the Securities Act of 1933, as amended (“Act”):

 

“The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (“Act”)
or the laws of applicable states or other jurisdictions. The securities may not be offered for sale, sold or otherwise transferred except
pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the Act and applicable
laws of states or other jurisdictions.”

 

2.3
Cashless Exercise.

 

2.3.1
Determination of Amount. In lieu of the payment of the Exercise Price multiplied by the number of Units for which this Purchase
Option is exercisable (and in lieu of being entitled to receive Shares and Warrants) in the manner required by Section 2.1, and
subject to Section 6.1 hereof, the Holder shall have the right (but not the obligation) to convert any exercisable but unexercised
portion of this Purchase Option into Units (“Cashless Exercise Right”) as follows: upon exercise of the Cashless
Exercise Right, the Company shall deliver to the Holder (without payment by the Holder of any of the Exercise Price in cash) that number
of Units (or that number of Shares, Warrants and Rights comprising that number of Units) equal to the number of Units to
be exercised multiplied by the quotient obtained by dividing (x) the “Value” (as defined below) of the portion of the Purchase
Option being converted by (y) the Current Market Value (as defined below). The “Value” of the portion of the
Purchase Option being converted shall equal the remainder derived from subtracting (a) (i) the Exercise Price multiplied by (ii) the
number of Units underlying the portion of this Purchase Option being converted from (b) the Current Market Value of a Unit multiplied
by the number of Units underlying the portion of the Purchase Option being converted. As used herein, the term “Current Market
Value” per Unit at any date means: (A) in the event that the Units, Shares, Public Rights, and Public Warrants are
still trading, (i) if the Units are listed on a national securities exchange or quoted on the OTC Bulletin Board or successor exchange,
the average reported last sale price of the Units in the principal trading market for the Units as reported by the exchange, Nasdaq or
the Financial Industry Regulatory Authority (“FINRA”), as the case may be, for the three trading days preceding
the date in question; or (ii) if the Units are not listed on a national securities exchange or quoted on the OTC Bulletin Board (or successor
exchange), but are traded in the residual over-the-counter market, the average reported last sale price for Units for the three trading
days preceding the date in question for which such quotations are reported by the Pink Sheets, LLC, or similar publisher of such quotations;
or (B) in the event that the Units are not still trading but the Shares, Public Warrants and Public Rights underlying the Units
are still trading, the aggregate of (i) the product of (x) the Current Market Price of the Shares and (y) the number of the Shares underlying
one Unit, plus (ii) the product of (x) the Current Market Price of the Public Warrants and (y) the number of Warrants included in one
Unit), plus (iii) the product of (x) the Current Market Price of the Public Rights and (y) the number of Rights included in one Unit;
(C) in the event that that the Units are not still trading, but the Shares, Public Warrants and Public Rights are still
trading, the aggregate of (i) the product of (x) the Current Market Price of the Shares and (y) the number of the Shares underlying one
Unit, plus (ii) the product of (x) the Current Market Price of the Public Warrants and (y) the number of Warrants included in one Unit,
plus (iii) the product of (x) the Current Market Price of the Public Rights and (y) the number of Rights included in one Unit;
or (D) in the event that neither the Units, the Public Warrants nor the Public Rights are still trading, the aggregate
of (i) the product of (x) the Current Market Price of the Shares and (y) the number of the Shares underlying one Unit, plus (ii) the
remainder derived from subtracting (x) the exercise price of the Warrants multiplied by the number of Shares issuable upon exercise of
the Warrants underlying one Unit from (y) the product of (aa) the Current Market Price of the Shares multiplied by (bb) the number of
Shares underlying the Warrants included in each such Unit, plus (iii) the remainder derived from subtracting (x) the exercise price
of the Rights multiplied by the number of Shares issuable upon exercise of the Rights underlying one Unit from (y) the product of (aa)
the Current Market Price of the Shares multiplied by (bb) the number of Shares underlying the Rights included in each such Unit.
The “Current Market Price” shall mean (i) if the Shares (or Public Warrants or Public Rights) are listed on a national
securities exchange or quoted on the OTC Bulletin Board (or successor exchange), the average reported last sale price of the Shares (or
Public Warrants or Public Rights) in the principal trading market for the Shares (or Public Warrants or Public Rights)
as reported by the exchange, Nasdaq or FINRA, as the case may be, for the three trading days preceding the date in question; (ii) if
the Shares (or Public Warrants or Public Rights) are not listed on a national securities exchange or quoted on the OTC Bulletin
Board (or successor exchange), but are traded in the residual over-the-counter market, the average reported last sale price for the Shares
(or Public Warrants or Public Rights) on for the three (3) trading days preceding the date in question for which such quotations
are reported by the Pink Sheets, LLC or similar publisher of such quotations; and (iii) if the fair market value of the Shares cannot
be determined pursuant to clause (i) or (ii) above, such price as the Board of Directors of the Company shall determine, in good faith.
In the event the Public Warrants or Public Rights have expired and are no longer exercisable, no “Value” shall be
attributed to the Warrants or Rights, respectively, underlying the Purchase Option.

 

    	 

     

    

 

2.3.2
Mechanics of Cashless Exercise. The Cashless Exercise Right may be exercised by the Holder on any business day on or after the
Commencement Date and not later than the Expiration Date by delivering the Purchase Option with the duly executed exercise form attached
hereto with the cashless exercise section completed to the Company, exercising the Cashless Exercise Right and specifying the total number
of Units the Holder will purchase pursuant to such Cashless Exercise Right.

 

2.4
No Obligation to Net Cash Settle. Notwithstanding anything to the contrary contained in this Purchase Option, in no event will
the Company be required to net cash settle the exercise of the Purchase Option or Warrants or Rights underlying the Purchase Option.
The holder of the Purchase Option and Warrants and Rights underlying the Purchase Option will not be entitled to exercise the
Purchase Option or the Warrants or Rights underlying such Purchase Option unless it exercises such Purchase Option pursuant to
the Cashless Exercise Right or a registration statement is effective, or an exemption from the registration requirements is available
at such time and, if the holder is not able to exercise the Purchase Option or underlying Warrants or Rights, the Purchase Option
and/or the underlying Warrants or Rights, will expire worthless.

 

3.
TRANSFER OF PURCHASE OPTION.

 

3.1
General Restrictions. The registered Holder of this Purchase Option, by its acceptance hereof, agrees that it will not sell, transfer,
assign, pledge or hypothecate this Purchase Option (or the Shares, Warrants and Rights underlying this Purchase Option),
or cause the Purchase Option (or the Shares, Warrants and Rights underlying this Purchase Option) to be the subject of
any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the Purchase
Option by any person, for a period of 180 days (pursuant to Rule 5110(e)(1) of the Conduct Rules of FINRA following the commencement
of sales of the Offering to anyone other than (i) Chardan or an underwriter or selected dealer in connection with the Offering, or (ii)
a bona fide officer or partner of Chardan or of any such underwriter or selected dealer. On and after the 181st day following the commencement
of sales of the Offering, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. In
order to make any permitted assignment, the Holder must deliver to the Company the assignment form attached hereto duly executed and
completed, together with the Purchase Option and payment of all transfer taxes, if any, payable in connection therewith. The Company
shall within 5 business days transfer this Purchase Option on the books of the Company and shall execute and deliver a new Purchase Option
of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Units purchasable hereunder
or such portion of such number as shall be contemplated by any such assignment.

 

3.2
Restrictions Imposed by the Act. The securities evidenced by this Purchase Option shall not be transferred unless and until (i)
the Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption from registration
under the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company
(the Company hereby agreeing that the opinion of Winston & Strawn LLP shall be deemed satisfactory evidence of the availability of
an exemption), or (ii) a registration statement or a post-effective amendment to the Registration Statement relating to such securities
has been filed by the Company and declared effective by the Securities and Exchange Commission (the “Commission”)
and compliance with applicable state securities law has been established.

 

4.
NEW PURCHASE OPTION TO BE ISSUED.

 

4.1
Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Option may be exercised or
assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Option
for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price (except
to the extent that the Holder elects to exercise this Purchase Option by means of a cashless exercise as provided in Section 2.3
above) and/or transfer tax, the Company shall cause to be delivered to the Holder without charge a new Purchase Option of like tenor
to this Purchase Option in the name of the Holder evidencing the right of the Holder to purchase the number of Units purchasable hereunder
as to which this Purchase Option has not been exercised or assigned

 

    	 

     

    

 

4.2
Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of
this Purchase Option and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a
new Purchase Option of like tenor and date. Any such new Purchase Option executed and delivered as a result of such loss, theft, mutilation
or destruction shall constitute a substitute contractual obligation on the part of the Company.

 

5.
REGISTRATION RIGHTS.

 

5.1
Demand Registration.

 

5.1.1
Grant of Right. The Company, upon written demand (“Initial Demand Notice”) of the Holder(s) of at least
51% of the Purchase Option and/or the underlying Units and/or the underlying securities (“Majority Holders”),
agrees to use its best efforts to register (the “Demand Registration”) under the Act on one (1) occasion, all
or any portion of the (i) Purchase Option requested by the Majority Holders in the Initial Demand Notice or all or any portion of the
securities underlying such Purchase Option, including the Units, Shares, Warrants and Rights (collectively, the “Registrable
Securities”). On such occasion, the Company will use its best efforts to file a registration statement or a post-effective
amendment to the Registration Statement covering the Registrable Securities as expeditiously as possible, and in any event within forty-five
(45) days, after receipt of the Initial Demand Notice and use its best efforts to have such registration statement or post-effective
amendment declared effective as soon as possible thereafter. The demand for registration may be made at any time during a period of five
years from the commencement of sales in the Offering. The Initial Demand Notice shall specify the number of shares of Registrable Securities
proposed to be sold and the intended method(s) of distribution thereof. The Company will notify all holders of the Purchase Option and/or
Registrable Securities of the demand within ten days from the date of the receipt of any such Initial Demand Notice. Each holder of Registrable
Securities who wishes to include all or a portion of such holder’s Registrable Securities in the Demand Registration (each such
holder including shares of Registrable Securities in such registration, a “Demanding Holder”) shall so notify
the Company within fifteen (15) days after the receipt by the holder of the notice from the Company. Upon any such request, the Demanding
Holders shall be entitled to have their Registrable Securities included in the Demand Registration, subject to Section 5.1.4.

 

5.1.2
Effective Registration. Notwithstanding Section 5.1.5, a registration will not count as a Demand Registration until the
registration statement filed with the Commission, with respect to such Demand Registration, has been declared effective and the Company
has complied with all of its obligations under this Purchase Option with respect thereto.

 

5.1.3
Underwritten Offering. If the Majority Holders so elect and such holders so advise the Company as part of the Initial Demand Notice,
the offering of such Registrable Securities pursuant to such Demand Registration shall be in the form of an underwritten offering. In
such event, the right of any holder to include its Registrable Securities in such registration shall be conditioned upon such holder’s
participation in such underwriting and the inclusion of such holder’s Registrable Securities in the underwriting to the extent
provided herein. All Demanding Holders proposing to distribute their securities through such underwriting shall enter into an underwriting
agreement in customary form with the underwriter or underwriters selected for such underwriting by the Majority Holders.

 

    	 

     

    

 

5.1.4
Reduction of Offering. If the managing underwriter or underwriters for a Demand Registration that is to be an underwritten offering
advises the Company and the Demanding Holders in writing that the dollar amount or number of shares of Registrable Securities which the
Demanding Holders desire to sell, taken together with all other Shares or other securities which the Company desires to sell and the
Shares, if any, as to which registration has been requested pursuant to written contractual piggy-back registration rights held by other
shareholders of the Company who desire to sell, exceeds the maximum dollar amount or maximum number of shares that can be sold in such
offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success
of such offering (such maximum dollar amount or maximum number of shares, as applicable, the “Maximum Number of Shares”),
then the Company shall include in such registration: (i) first, the Registrable Securities as to which Demand Registration has been requested
by the Demanding Holders (pro rata in accordance with the number of shares that each such person has requested be included in such registration,
regardless of the number of shares held by each such person (such proportion is referred to herein as “Pro Rata”))
that can be sold without exceeding the Maximum Number of Shares; (ii) second, to the extent that the Maximum Number of Shares has not
been reached under the foregoing clause (i), the Shares or other securities that the Company desires to sell that can be sold without
exceeding the Maximum Number of Shares; (iii) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing
clauses (i) and (ii), the Shares or other securities registrable pursuant to the terms of the Registration Rights Agreement between the
Company and the initial investors in the Company, dated as of [●] (the “Registration Rights Agreement”
and such registrable securities, the “Investor Securities”) as to which “piggy-back” registration
has been requested by the holders thereof, Pro Rata, that can be sold without exceeding the Maximum Number of Shares; and (iv) fourth,
to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (i), (ii), and (iii), the Shares or
other securities for the account of other persons that the Company is obligated to register pursuant to written contractual arrangements
with such persons and that can be sold without exceeding the Maximum Number of Shares.

 

5.1.5
Withdrawal. If a majority-in-interest of the Demanding Holders disapprove of the terms of any underwriting or are not entitled
to include all of their Registrable Securities in any offering, such majority-in-interest of the Demanding Holders may elect to withdraw
from such offering by giving written notice to the Company and the underwriter or underwriters of their request to withdraw prior to
the effectiveness of the registration statement filed with the Commission with respect to such Demand Registration. If the majority-in-interest
of the Demanding Holders withdraws from a proposed offering relating to a Demand Registration, then the Company does not have to continue
its obligations under Section 5.1, provided that, any such withdrawal will not count as the Demand Registration if the
Demanding Holders pay all of the Company’s out-of-pocket expenses, with respect to such withdrawn registration.

 

5.1.6
Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities, including the expenses
of one legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities, but the Holders
shall pay any and all underwriting commissions. The Company agrees to use its reasonable best efforts to qualify or register the Registrable
Securities in such states as are reasonably requested by the Majority Holder(s); provided, however, that in no event shall
the Company be required to register the Registrable Securities in a state in which such registration would cause (i) the Company to be
obligated to qualify to do business in such state, or would subject the Company to taxation as a foreign corporation doing business in
such jurisdiction or (ii) the principal shareholders of the Company to be obligated to escrow their shares of capital stock of the Company.
The Company shall use its best efforts to cause any registration statement or post-effective amendment filed pursuant to the demand rights
granted under Section 5.1.1 to remain effective for a period of nine consecutive months from the effective date of such registration
statement or post-effective amendment.

 

5.2
Piggy-Back Registration.

 

5.2.1
Piggy-Back Rights This Agreement grants to holders one demand and one unlimited “piggy-back” rights for periods of
five and seven years, respectively, commencing on the date of commencement of sales in the Offering. If the Company proposes to
file a registration statement under the Act with respect to an offering of equity securities, or securities or other obligations exercisable
or exchangeable for, or convertible into, equity securities, by the Company for its own account or for shareholders of the Company for
their account (or by the Company and by shareholders of the Company including, without limitation, pursuant to Section 5.1), other
than a registration statement (i) filed in connection with any employee share option or other benefit plan, (ii) for an exchange offer
or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that is convertible into
equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall (x) give written notice of such proposed
filing to the holders of Registrable Securities as soon as practicable but in no event less than ten (10) days before the anticipated
filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of
distribution, and the name of the proposed managing underwriter or underwriters, if any, of the offering, and (y) offer to the holders
of Registrable Securities in such notice the opportunity to register the sale of such number of shares of Registrable Securities as such
holders may request in writing within five (5) days following receipt of such notice (a “Piggy-Back Registration”).
The Company shall cause such Registrable Securities to be included in such registration and shall use its best efforts to cause the managing
underwriter or underwriters of a proposed underwritten offering to permit the Registrable Securities requested to be included in a Piggy-Back
Registration on the same terms and conditions as any similar securities of the Company and to permit the sale or other disposition of
such Registrable Securities in accordance with the intended method(s) of distribution thereof. All holders of Registrable Securities
proposing to distribute their securities through a Piggy-Back Registration that involves an underwriter or underwriters shall enter into
an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggy-Back Registration.

 

    	 

     

    

 

5.2.2
Reduction of Offering. If the managing underwriter or underwriters for a Piggy-Back Registration that is to be an underwritten
offering advises the Company and the holders of Registrable Securities in writing that the dollar amount or number of Registrable Securities
which the Company desires to sell, taken together with securities, if any, as to which registration has been demanded pursuant to written
contractual arrangements with persons other than the holders of Registrable Securities hereunder, the Registrable Securities as to which
registration has been requested under this Section 5.2, and the securities, if any, as to which registration has been requested
pursuant to the written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number of
Shares, then the Company shall include in any such registration:

 

(a)
If the registration is undertaken for the Company’s account: (A) first, Shares or other securities that the Company desires to
sell that can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum Number of Shares has
not been reached under the foregoing clause (A), the Shares or other securities, if any, comprised of Registrable Securities and Investor
Securities, as to which registration has been requested pursuant to the applicable written contractual piggy-back registration rights
of such security holders, Pro Rata, that can be sold without exceeding the Maximum Number of Shares; and (C) third, to the extent that
the Maximum Number of shares has not been reached under the foregoing clauses (A) and (B), the Shares or other securities for the account
of other persons that the Company is obligated to register pursuant to written contractual piggy-back registration rights with such persons
and that can be sold without exceeding the Maximum Number of Shares;

 

(b)
If the registration is a “demand” registration undertaken at the demand of holders of Investor Securities, (A) first, the
Shares or other securities for the account of the demanding persons, Pro Rata, that can be sold without exceeding the Maximum Number
of Shares; (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the Shares
or other securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Shares; (C) third, to the
extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B), the shares of Registrable Securities,
Pro Rata, as to which registration has been requested pursuant to the terms hereof, that can be sold without exceeding the Maximum Number
of Shares; and (D) fourth, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A), (B)
and (C), the Shares or other securities for the account of other persons that the Company is obligated to register pursuant to written
contractual arrangements with such persons, that can be sold without exceeding the Maximum Number of Shares; and

 

(c)
If the registration is a “demand” registration undertaken at the demand of persons other than either the holders of Registrable
Securities or of Investor Securities, (A) first, the Shares or other securities for the account of the demanding persons that can be
sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum Number of Shares has not been reached
under the foregoing clause (A), the Shares or other securities that the Company desires to sell that can be sold without exceeding the
Maximum Number of Shares; (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses
(A) and (B), collectively the Shares or other securities comprised of Registrable Securities and Investor Securities, Pro Rata, as to
which registration has been requested pursuant to the terms hereof and of the Registration Rights Agreement, as applicable, that can
be sold without exceeding the Maximum Number of Shares; and (D) fourth, to the extent that the Maximum Number of Shares has not been
reached under the foregoing clauses (A), (B) and (C), the Shares or other securities for the account of other persons that the Company
is obligated to register pursuant to written contractual arrangements with such persons, that can be sold without exceeding the Maximum
Number of Shares.

 

5.2.3
Withdrawal. Any holder of Registrable Securities may elect to withdraw such holder’s request for inclusion of Registrable
Securities in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness
of the registration statement. The Company (whether on its own determination or as the result of a withdrawal by persons making a demand
pursuant to written contractual obligations) may withdraw a registration statement at any time prior to the effectiveness of the registration
statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the holders of Registrable Securities
in connection with such Piggy-Back Registration as provided in Section 5.2.4.

 

    	 

     

    

 

5.2.4
Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities, including the expenses
of one legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities but the Holders
shall pay any and all underwriting commissions related to the Registrable Securities. In the event of such a proposed registration, the
Company shall furnish the then Holders of outstanding Registrable Securities with not less than fifteen days written notice prior to
the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each applicable
registration statement filed (during the period in which the Purchase Option is exercisable) by the Company until such time as all of
the Registrable Securities have been registered and sold. The Holders of the Registrable Securities shall exercise the “piggy-back”
rights provided for herein by giving written notice within ten days of the receipt of the Company’s notice of its intention to
file a registration statement. The Company shall use its best efforts to cause any registration statement filed pursuant to the above
“piggyback” rights to remain effective for at least nine months from the date that the Holders of the Registrable Securities
are first given the opportunity to sell all of such securities.

 

5.3
General Terms.

 

5.3.1
Indemnification. The Company shall, to the fullest extent permitted by applicable law, indemnify the Holder(s) of the Registrable
Securities to be sold pursuant to any registration statement hereunder and each person, if any, who controls such Holders within the
meaning of Section 15 of the Act or Section 20(a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”),
against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred
in investigating, preparing or defending against litigation, commenced or threatened, or any claim whatsoever whether arising out of
any action between the underwriter and the Company or between the underwriter and any third party or otherwise) to which any of them
may become subject under the Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent
and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the underwriters contained in [Section
5 of the Underwriting Agreement]1 between the Company, Chardan and the other underwriters named therein dated [●]
(“Underwriting Agreement”). The Holder(s) of the Registrable Securities to be sold pursuant to such registration
statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, its officers and directors and
each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act, against
all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Act, the Exchange Act
or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific
inclusion in such registration statement or arising from any omission or the alleged omission to state a material fact required to be
stated therein or necessary to make the statement contained therein not misleading in connection with the registration of the Registrable
Securities, to the same extent and with the same effect as the provisions contained in [Section 5 of the Underwriting Agreement]2
pursuant to which the underwriters have agreed to indemnify the Company.

 

5.3.2
Exercise of Purchase Option. Nothing contained in this Purchase Option shall be construed as requiring the Holder(s) to exercise
their Purchase Option or Warrants or Rights underlying such Purchase Option prior to or after the initial filing of any registration
statement or the effectiveness thereof.

 

 

1
                                            NTD: To be confirmed.

2
NTD: To be confirmed.

 

    	 

     

    

 

5.3.3
Documents Delivered to Holders. The Company shall furnish Chardan, as representative of the Holders participating in any of the
foregoing offerings, a signed counterpart, addressed to the participating Holders, of (i) an opinion of counsel to the Company, dated
the effective date of such registration statement (and, if such registration includes an underwritten public offering, an opinion dated
the date of the closing under any underwriting agreement related thereto), and (ii) a “cold comfort” letter dated the effective
date of such registration statement (and, if such registration includes an underwritten public offering, a letter dated the date of the
closing under the underwriting agreement) signed by the independent public accountants who have issued a report on the Company’s
financial statements included in such registration statement, in each case covering substantially the same matters with respect to such
registration statement (and the prospectus included therein) and, in the case of such accountants’ letter, with respect to events
subsequent to the date of such financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants’
letters delivered to underwriters in underwritten public offerings of securities. The Company shall also deliver promptly to Chardan,
as representative of the Holders participating in the offering, the correspondence and memoranda described below and copies of all correspondence
between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or its
staff with respect to the registration statement and permit Chardan, as representative of the Holders, to do such investigation, upon
reasonable advance notice, with respect to information contained in or omitted from the registration statement as it deems reasonably
necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and
properties and opportunities to discuss the business of the Company with its officers and independent auditors, all to such reasonable
extent and at such reasonable times and as often as Chardan, as representative of the Holders, shall reasonably request. The Company
shall not be required to disclose any confidential information or other records to Chardan, as representative of the Holders, or to any
other person, until and unless such persons shall have entered into reasonable confidentiality agreements (in form and substance reasonably
satisfactory to the Company), with the Company with respect thereto.

 

5.3.4
Underwriting Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected
by any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall
be reasonably acceptable to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder
and such managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms
as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting
agreement relating to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the representations,
warranties and covenants of the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such
Holders. Such Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters
except as they may relate to such Holders and their intended methods of distribution. Such Holders, however, shall agree to such covenants
and indemnification and contribution obligations for selling shareholders as are customarily contained in agreements of that type used
by the managing underwriter. Further, such Holders shall execute appropriate custody agreements and otherwise cooperate fully in the
preparation of the registration statement and other documents relating to any offering in which they include securities pursuant to this
Section 5. Each Holder shall also furnish to the Company such information regarding itself, the Registrable Securities held by
it, and the intended method of disposition of such securities as shall be reasonably required to effect the registration of the Registrable
Securities.

 

5.3.5
Rule 144 Sale. Notwithstanding anything contained in this Section 5 to the contrary, the Company shall have no obligation
pursuant to Sections 5.1 or 5.2 to use its best efforts to obtain the registration of Registrable Securities held by any
Holder (i) where such Holder would then be entitled to sell under Rule 144 within any three-month period (or such other period prescribed
under Rule 144 as may be provided by amendment thereof) all of the Registrable Securities then held by such Holder, or (ii) where the
number of Registrable Securities held by such Holder is within the volume limitations under paragraph (e) of Rule 144 (calculated as
if such Holder were an affiliate within the meaning of Rule 144).

 

5.3.6
Supplemental Prospectus. Each Holder agrees, that upon receipt of any notice from the Company of the happening of any event as
a result of which the prospectus included in the registration statement, as then in effect, includes an untrue statement of a material
fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light
of the circumstances then existing, such Holder will immediately discontinue disposition of Registrable Securities pursuant to the registration
statement covering such Registrable Securities until such Holder’s receipt of the copies of a supplemental or amended prospectus,
and, if so desired by the Company, such Holder shall deliver to the Company (at the expense of the Company) or destroy (and deliver to
the Company a certificate of such destruction) all copies, other than permanent file copies then in such Holder’s possession, of
the prospectus covering such Registrable Securities current at the time of receipt of such notice.

 

    	 

     

    

 

6.
ADJUSTMENTS.

 

6.1
Adjustments to Exercise Price and Number of Securities. The Exercise Price and the number of Units underlying the Purchase Option
shall be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1
Share Dividends - Split-Ups. If after the date hereof, and subject to the provisions of Section 6.3 below, the number of
outstanding ordinary shares of the Company is increased by a share dividend payable in shares or by a split-up of shares or other similar
event, then, on the effective date thereof, the number of Shares underlying each of the Units (which shall include the shares underlying
the Rights the holder of the Units would automatically receive in connection with the Rights included in the Units) shall be increased
in proportion to such increase in outstanding shares. In such case, the number of Shares, and the exercise price applicable thereto,
underlying the Warrants underlying each of the Units purchasable hereunder shall be adjusted in accordance with the terms of the Warrants.

 

6.1.2
Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 6.3, the number of outstanding
ordinary shares of the Company is decreased by a consolidation, combination or reclassification of Shares or other similar event, then,
on the effective date thereof, the number of Shares underlying each of the Units (which shall include the shares underlying the Rights
the holder of the Units would automatically receive in connection with the Rights included in the Units) shall be decreased in proportion
to such decrease in outstanding shares and the Exercise Price shall be proportionately increased. In such case, the number of Shares,
and the exercise price applicable thereto underlying the Warrants underlying each of the Units purchasable hereunder shall be adjusted
in accordance with the terms of the Warrants.

 

6.1.3
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding ordinary
shares of the Company other than a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value
of such shares, or in the case of any merger or consolidation of the Company with or into another company (other than a consolidation
or merger in which the Company is the continuing entity and that does not result in any reclassification or reorganization of the outstanding
Shares), or in the case of any sale or conveyance to another company or entity of the property of the Company as an entirety or substantially
as an entirety in connection with which the Company is dissolved, the Holder of this Purchase Option shall have the right thereafter
(until the expiration of the right of exercise of this Purchase Option) to receive upon the exercise hereof, for the same aggregate Exercise
Price payable hereunder immediately prior to such event, the kind and amount of shares or other securities or property (including cash)
receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
by a Holder of the number of Shares of the Company obtainable upon exercise of this Purchase Option and the underlying Warrants and
Rights immediately prior to such event; and if any reclassification also results in a change in Shares covered by Section 6.1.1
or 6.1.2, then such adjustment shall be made pursuant to Sections 6.1.1, 6.1.2 and this Section 6.1.3.
The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers.

 

6.1.4
Changes in Form of Purchase Option. This form of Purchase Option need not be changed because of any change pursuant to this Section,
and a Purchase Option issued after such change may state the same Exercise Price and the same number of Units as are stated in the Purchase
Option as initially issued. The acceptance by any Holder of the issuance of a new Purchase Option reflecting a required or permissive
change shall not be deemed to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.

 

6.2
Substitute Purchase Option. In case of any consolidation of the Company with, or merger of the Company with, or merger of the
Company into, another entity (other than a consolidation or merger which does not result in any reclassification or change of the outstanding
ordinary shares of the Company), the entity formed by such consolidation or merger shall execute and deliver to the Holder a supplemental
Purchase Option providing that the holder of each Purchase Option then outstanding or to be outstanding shall have the right thereafter
(until the stated expiration of such Purchase Option) to receive, upon exercise of such Purchase Option, the kind and amount of shares
and other securities and property receivable upon such consolidation or merger, by a holder of the number of Shares of the Company for
which such Purchase Option might have been exercised immediately prior to such consolidation, merger, sale or transfer. Such supplemental
Purchase Option shall provide for adjustments which shall be identical to the adjustments provided in Section 6. The above provision
of this Section shall similarly apply to successive consolidations or mergers.

 

6.3
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares,
Warrants or Rights upon the exercise of the Purchase Option, nor shall it be required to issue scrip or pay cash in lieu of
any fractional interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction
up to the nearest whole number of Warrants, Rights, Shares or other securities, properties or rights (or as otherwise provided
pursuant to the Warrant Agreement or Rights Agreement, as the case may be).

 

    	 

     

    

 

7.
RESERVATION AND LISTING. The Company shall at all times reserve and keep available
out of its authorized but unissued Shares, solely for the purpose of issuance upon exercise of the Purchase Option or the Warrants or
Rights underlying the Purchase Option, such number of Shares or other securities, properties or rights as shall be issuable upon
the exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Option and payment of the Exercise Price therefor,
all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and not subject
to preemptive rights of any shareholders. The Company further covenants and agrees that upon exercise of the Warrants underlying the
Purchase Option and payment of the respective Warrant exercise price therefor, all Shares and other securities issuable upon such exercise
shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholders. As long as
the Purchase Option shall be outstanding, the Company shall use its best efforts to cause all (i) Units and Shares issuable upon exercise
of the Purchase Option, (ii) Warrants issuable upon exercise of the Purchase Option, (iii) Rights issuable upon exercise of the Purchase
Option, (iv) Shares issuable upon exercise of the Warrants included in the Units issuable upon exercise of the Purchase Option, (v)
Shares issuable upon exercise of the Rights included in the Units issuable upon exercise of the Purchase Option and (vi) Shares
underlying the Units issuable upon exercise of the Purchase Option to be listed and/or quoted (subject to official notice of issuance)
on all securities exchanges (or, if applicable, on the OTC Bulletin Board or OTC Markets Group, Inc. or any successor trading market)
on which the Units, Shares, Warrants or Rights may then be listed and/or quoted.

 

8.
CERTAIN NOTICE REQUIREMENTS.

 

8.1
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or
consent as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the
Company. If, however, at any time prior to the expiration of the Purchase Option and its exercise, any of the events described in Section
8.2 shall occur, then, in each such event, the Company shall give written notice of such event at least fifteen days prior to the
date fixed as a record date or the date of closing the transfer books for the determination of the shareholders entitled to such dividend,
distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation,
winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be.
Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the
Company at the same time and in the same manner that such notice is given to the shareholders.

 

8.2
Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more
of the following events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive
a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained
earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company, or (ii) the Company
shall offer to all the holders of its Shares any additional shares of capital share of the Company or securities convertible into or
exchangeable for shares of capital share of the Company, or any option, or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or merger) or a sale of all or substantially all of its property,
assets and business shall be proposed.

 

8.3
Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant
to Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price
Notice shall describe the event causing the change and the method of calculating same and shall be certified as being true and accurate
by the Company’s Chief Executive Officer.

 

8.4
Transmittal of Notices. All notices, requests, consents and other communications under this Purchase Option shall be in writing
and shall be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
Holder of the Purchase Option, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company, to the
following address or to such other address as the Company may designate by notice to the Holders:

 

    	 

     

    

 

AlphaTime
Acquisition Corp

500
5th Avenue, Suite 938

New
York, New York 10110

Attn:
Dajiang Guo, Chief Executive Officer

Telephone:
(347) 627-0058

 

9.
MISCELLANEOUS.

 

9.1
Amendment The Company and Chardan may from time to time supplement or amend this Purchase Option without the approval of any of
the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent
with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Chardan may deem necessary or desirable and that the Company and Chardan deem shall not adversely affect the interest of the Holders.
All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement of the
modification or amendment is sought.

 

9.2
Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Purchase Option.

 

9.3
Entire Agreement. This Purchase Option (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Option) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4
Binding Effect. This Purchase Option shall inure solely to the benefit of and shall be binding upon the Holder and the Company
and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed
to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Option or any provisions herein
contained.

 

9.5
Governing Law; Submission to Jurisdiction. This Purchase Option shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. Each of the Holder and the Company
hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Option shall be
brought and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District
of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. Each of the Holder and the Company
hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons
to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested,
postage prepaid, addressed to it at the address set forth in Section 8.4 hereof. Such mailing shall be deemed personal service
and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and
expenses relating to such action or proceeding and/or incurred in connection with the preparation therefore.

 

9.6
Waiver, Etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Option shall
not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Option or any
provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Option. No
waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Option shall be effective unless set
forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver
of any such breach, non-compliance or non- fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach
or non-compliance.

 

9.7
Execution in Counterparts. This Purchase Option may be executed in one or more counterparts, and by the different parties hereto
in separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto.

 

9.8
Exchange Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Option, Holder agrees that, at
any time prior to the complete exercise of this Purchase Option by Holder, if the Company and Chardan enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Options will be exchanged for securities or cash
or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

    	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Purchase Option to be signed by its duly authorized officer as of the ___ day of _______,
20__.

	 	ALPHATIME
    ACQUISITION CORP
	 	 
	 	By:	 
	 	Name:	Dajiang
    Guo
	 	Title:	Chief
    Executive Officer

 

Signature
Page to Purchase Option

 

    	 

     

    

 

Form
to be used to exercise Purchase Option

 

AlphaTime
Acquisition Corp

500
5th Avenue, Suite 938,

New
York, New York 10110

 

Date:_________________,
20___

 

The
undersigned hereby elects irrevocably to exercise all or a portion of the within Purchase Option and to purchase ____ Units of AlphaTime
Acquisition Corp and hereby makes payment of $____________ (at the rate of $_________ per Unit) in payment of the Exercise Price pursuant
thereto. Please issue the securities as to which this Purchase Option is exercised in accordance with the instructions given below.

 

Or

 

The
undersigned hereby elects irrevocably to convert its right to purchase _________ Units purchasable under the within Purchase Option by
surrender of the unexercised portion of the attached Purchase Option (with a “Value” based of $_______ based on a “Market
Price” of $_______). Please issue the securities comprising the Units as to which this Purchase Option is exercised in accordance
with the instructions given below.

 

NOTICE:
The signature to this assignment must correspond with the name as written upon the face of the purchase option in every particular, without
alteration or enlargement or any change whatever

 

Signature(s)
Guaranteed:

THE
SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT
UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO

S.E.C.
RULE 17Ad-15).

 

    	 

     

    

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

 

	Name
	 
	(Print in Block Letters)
	Address

Form to be used to assign Purchase Option:

 

ASSIGNMENT

 

(To
be executed by the registered Holder to effect a transfer of the within Purchase Option):

 

FOR
VALUE RECEIVED,____________________________________________ does hereby sell, assign and transfer unto___________________________________________
the right to purchase __________ Units of AlphaTime Acquisition Corp (“Company”) evidenced by the within Purchase
Option and does hereby authorize the Company to transfer such right on the books of the Company.

 

Dated:___________________,
20___

 

	 	 
	 	Signature
	 	 

	 	 
	 	NOTICE:
    The signature to this assignment must correspond with the name as written upon the face of the purchase option in every particular,
    without alteration or enlargement or any change whatever.

 

Signature(s)
Guaranteed:

 

THE
SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT
UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).Exhibit
4.7

 

RIGHTS
AGREEMENT

 

This
Rights Agreement (this “Agreement”) is made as of [•], 2022 between AlphaTime Acquisition Corp, a Cayman
Islands exempted company (the “Company”), and American Stock Transfer & Trust Company, a limited purpose
trust company, as rights agent (the “Rights Agent”).

 

WHEREAS,
the Company has received a firm commitment from Alphamade Holding LP, a Delaware limited liability company (the “Sponsor”),
to purchase up to an aggregate of 370,500 private units (or up to 409,200 private units if the over-allotment option is
exercised in full or in part) in a private placement transaction to occur simultaneously with the consummation of the Company’s
initial public offering (the “Public Offering”), with each unit (“Unit”) comprised
of one ordinary share of the Company, par value $0.001 per share (the “Shares”), one redeemable warrant and
one right to receive one-tenth (1/10) of one Share (the “Rights”);

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form
S-1 (File No. 333-[•]) (“Registration Statement”), for the registration, under the Securities Act of 1933,
as amended (“Act”), of, among other securities, the Rights and the Shares issuable in the Public Offering;

 

WHEREAS,
the Company desires the Rights Agent to act on behalf of the Company, and the Rights Agent is willing to so act, in connection with the
issuance, registration, transfer and exchange of the Rights;

 

WHEREAS,
the Company desires to provide for the form and provisions of the Rights, the terms upon which they shall be issued, and the respective
rights, limitation of rights, and immunities of the Company, the Rights Agent, and the holders of the Rights; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Rights, when executed on behalf of the Company and countersigned
by or on behalf of the Rights Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the
execution and delivery of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

	1.	Appointment
    of Rights Agent. The Company hereby appoints the Rights Agent to act as agent for the Company for the Rights, and the Rights Agent
    hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

 

	2.	Rights.

 

	 	2.1.	Form
    of Right. Each Right shall be issued in registered form only, shall be in substantially the form of Exhibit A hereto, the provisions
    of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board or Chief Executive
    Officer and Treasurer, Secretary or Assistant Secretary of the Company and shall bear a facsimile of the Company’s seal. In
    the event the person whose facsimile signature has been placed upon any Right shall have ceased to serve in the capacity in which
    such person signed the Right before such Right is issued, it may be issued with the same effect as if he or she had not ceased to
    be such at the date of issuance.

 

    	 

    	 

    

 

 

	 	2.2.	Effect
    of Countersignature. Unless and until countersigned by the Rights Agent pursuant to this Agreement, a Right shall be invalid and
    of no effect and may not be exchanged for Shares. 

 

	 	2.3.	Registration.

 

	 	2.3.1.	Right
    Register. The Rights Agent shall maintain books (“Right Register”) for the registration of original issuance
    and the registration of transfer of the Rights. Upon the initial issuance of the Rights, the Rights Agent shall issue and register
    the Rights in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered
    to the Rights Agent by the Company.

 

	 	2.3.2.	Registered
    Holder. Prior to due presentment for registration of transfer of any Right, the Company and the Rights Agent may deem and treat the
    person in whose name such Right shall be registered upon the Right Register (“registered holder”) as the
    absolute owner of such Right and of each Right represented thereby (notwithstanding any notation of ownership or other writing on
    the Right Certificate made by anyone other than the Company or the Rights Agent), for the purpose of the exchange thereof, and for
    all other purposes, and neither the Company nor the Rights Agent shall be affected by any notice to the contrary.

 

	 	2.4.	Detachability
    of Rights. The securities comprising the Units, including the Rights, will not be separately transferable until the 90th day after
    the date hereof unless the Representative informs the Company of its decision to allow earlier separate trading, but in no event
    will separate trading of the securities comprising the Units begin until (i) the Company files a Current Report on Form 8-K which
    includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Public Offering including the
    proceeds received by the Company from the exercise of the over-allotment option, if the over-allotment option is exercised on the
    date hereof, and (ii) the Company issues a press release and files a Current Report on Form 8-K announcing when such separate trading
    shall begin.

 

	3.	Terms
    and Exchange of Rights.

 

	 	3.1.	Rights.
    Each Right shall entitle the holder thereof to receive one-tenth of one Share upon the happening of the Exchange Event (described
    below). Subject to Section 3.3.1 below with respect to the registered holders of Rights, in the event that the Company is not the
    surviving entity immediately following the Exchange Event, holders of Rights shall be entitled to automatically receive the kind
    and amount of securities or properties of the surviving entity as the holders of each one-tenth of one Share is entitled to receive
    in the Exchange Event. No additional consideration shall be paid by a holder of Rights in order to receive his, her or its Share
    upon the Exchange Event as the purchase price for such Shares has been included in the purchase price for the Units. In no event
    will the Company be required to net cash settle the Rights or issue fractional Shares.

 

    	 

    	 

    

 

 

	 	3.2.	Exchange
    Event. The Exchange Event shall be the Company’s consummation of an initial Business Combination (as defined in the Company’s
    Amended and Restated Memorandum and Articles of Association).

 

	 	3.3.	Exchange
    of Rights.

 

	 	3.3.1.	Issuance
    of Certificates. As soon as practicable upon the occurrence of the Exchange Event, the Company shall direct registered holders of
    the Rights to return their Right Certificates to the Rights Agent subject to dissenter rights as provided in the applicable law if
    any in the event that the Company is not the surviving entity in a Business Combination. Upon receipt of a valid Right Certificate,
    the Company shall issue to the registered holder of such Right(s) a certificate or certificates for the number of full Shares to
    which he, she or it is entitled, registered in such name or names as may be directed by him, her or it. Notwithstanding the foregoing,
    or any provision contained in this Agreement to the contrary, in no event will the Company be required to net cash settle the Rights.
    The Company shall not issue fractional shares upon exchange of Rights. At the time of the Exchange Event, the Company will instruct
    the Rights Agent to round down to the nearest whole Share or otherwise inform it how fractional shares will be addressed in accordance
    with Cayman Islands law as the same may be amended from time to time. 

 

	 	3.3.2.	Valid
    Issuance. All Shares issued upon an Exchange Event in conformity with this Agreement shall be validly issued, fully paid and nonassessable.

 

	 	3.3.3.	Date
    of Issuance. Each person in whose name any such certificate for Shares is issued shall for all purposes be deemed to have become
    the holder of record of such shares on the date of the Exchange Event, irrespective of the date of delivery of such certificate.

 

	 	3.3.4.	Company
    Not Surviving Following Exchange Event. If the Exchange Event results in the Company not continuing as a publicly held reporting
    entity, the definitive agreement will provide for the holders of Rights to receive the same per share consideration as the holders
    of the Shares will receive in with the Exchange Event, for the number of shares such holder is entitled to pursuant to Section 3.3.1
    above.

 

	 	3.4.	Duration
    of Rights. If the Exchange Event does not occur within 9 months from the closing of the Public Offering (or up to 18 months from
    the closing of the Public Offering if the Company extends the period of time to consummate a Business Combination, as described in
    the Registration Statement), and such Business Combination has not yet been consummated within the applicable time period, the Rights
    shall expire and shall be worthless.

 

    	 

    	 

    

 

	4.	Transfer
    and Exchange of Rights.

 

	 	4.1.	Registration
    of Transfer. The Rights Agent shall register the transfer, from time to time, of any outstanding Right upon the Right Register, upon
    surrender of such Right for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions
    for transfer. Upon any such transfer, a new Right representing an equal aggregate number of Rights shall be issued and the old Right
    shall be cancelled by the Rights Agent. The Rights so cancelled shall be delivered by the Rights Agent to the Company from time to
    time upon request.

 

	 	4.2.	Procedure
    for Surrender of Rights. Rights may be surrendered to the Rights Agent, together with a written request for exchange or transfer,
    and thereupon the Rights Agent shall issue in exchange therefor one or more new Rights as requested by the registered holder of the
    Rights so surrendered, representing an equal aggregate number of Rights; provided, however, that in the event that a Right surrendered
    for transfer bears a restrictive legend, the Rights Agent shall not cancel such Right and issue new Rights in exchange therefor until
    the Rights Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether
    the new Rights must also bear a restrictive legend.

 

	 	4.3.	Fractional
    Rights. The Rights Agent shall not be required to effect any registration of transfer or exchange which will result in the issuance
    of a Right Certificate for a fraction of a Right.

 

	 	4.4.	Service
    Charges. No service charge shall be made for any exchange or registration of transfer of Rights.

 

	 	4.5.	Adjustments
    to Conversion Ratios. The number of Shares that the holders of Rights are entitled to receive as a result of the occurrence of an
    Exchange Event shall be equitably adjusted to reflect appropriately the effect of any stock split, stock dividend, reorganization,
    recapitalization, reclassification, combination, exchange of stock or other like change with respect to Shares occurring on or after
    the date hereof and prior to the Exchange Event.

 

	 	4.6.	Right
    Execution and Countersignature. The Rights Agent is hereby authorized to countersign and to deliver, in accordance with the terms
    of this Agreement, the Rights required to be issued pursuant to the provisions of this Section 4, and the Company, whenever required
    by the Rights Agent, will supply the Rights Agent with Rights duly executed on behalf of the Company for such purpose.

 

	5.	Other
    Provisions Relating to Rights of Holders of Rights.

 

	 	5.1.	No
    Rights as Stockholder. Until exchange of a Right for Shares as provided for herein, a Right does not entitle the registered holder
    thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other
    distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings
    of stockholders or the election of directors of the Company or any other matter.

 

    	 

    	 

    

 

	 	5.2.	Lost,
    Stolen, Mutilated, or Destroyed Rights. If any Right is lost, stolen, mutilated, or destroyed, the Company and the Rights Agent may
    on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Right,
    include the surrender thereof), issue a new Right of like denomination, tenor, and date as the Right so lost, stolen, mutilated,
    or destroyed. Any such new Right shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
    lost, stolen, mutilated, or destroyed Right shall be at any time enforceable by anyone.

 

	 	5.3.	Reservation
    of Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued Shares that will be
    sufficient to permit the exchange of all outstanding Rights issued pursuant to this Agreement.

 

	6.	Concerning
    the Rights Agent and Other Matters.

 

	 	6.1.	Payment
    of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Rights
    Agent in respect of the issuance or delivery of the Shares upon the exchange of Rights, but the Company shall not be obligated to
    pay any transfer taxes in respect of the Rights or such shares.

 

	 	6.2.	Resignation,
    Consolidation, or Merger of Rights Agent.

 

	 	6.2.1.	Appointment
    of Successor Rights Agent. The Rights Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
    from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office
    of the Rights Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
    Rights Agent in place of the Rights Agent. If the Company shall fail to make such appointment within a period of 30 days after it
    has been notified in writing of such resignation or incapacity by the Rights Agent or by the holder of the Right (who shall, with
    such notice, submit his, her or its Right for inspection by the Company), then the holder of any Right may apply to the Supreme Court
    of the State of New York for the County of New York for the appointment of a successor Rights Agent at the Company’s cost.
    Any successor Rights Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under
    the laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of
    New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal
    or state authority. After appointment, any successor Rights Agent shall be vested with all the authority, powers, rights, immunities,
    duties, and obligations of its predecessor Rights Agent with like effect as if originally named as Rights Agent hereunder, without
    any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Rights Agent shall execute and
    deliver, at the expense of the Company, an instrument transferring to such successor Rights Agent all the authority, powers, and
    rights of such predecessor Rights Agent hereunder; and upon request of any successor Rights Agent the Company shall make, execute,
    acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor
    Rights Agent all such authority, powers, rights, immunities, duties, and obligations.

 

    	 

    	 

    

 

	 	6.2.2.	Notice
    of Successor Rights Agent. In the event a successor Rights Agent shall be appointed, the Company shall give notice thereof to the
    predecessor Rights Agent and the transfer agent for the Shares not later than the effective date of any such appointment.

 

	 	6.2.3.	Merger
    or Consolidation of Rights Agent. Any corporation into which the Rights Agent may be merged or with which it may be consolidated
    or any corporation resulting from any merger or consolidation to which the Rights Agent shall be a party shall be the successor Rights
    Agent under this Agreement without any further act.

 

	 	6.3.	Fees
    and Expenses of Rights Agent.

 

	 	6.3.1.	Remuneration.
    The Company agrees to pay the Rights Agent reasonable remuneration for its services as such Rights Agent hereunder and will reimburse
    the Rights Agent upon demand for all expenditures that the Rights Agent may reasonably incur in the execution of its duties hereunder.

 

	 	6.3.2.	Further
    Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
    delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Rights Agent for the
    carrying out or performing of the provisions of this Agreement.

 

	 	6.4.	Liability
    of Rights Agent.

 

	 	6.4.1.	Reliance
    on Company Statement. Whenever in the performance of its duties under this Agreement, the Rights Agent shall deem it necessary or
    desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such
    fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved
    and established by a statement signed by the Chief Executive Officer or Chief Financial Officer and delivered to the Rights Agent.
    The Rights Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of
    this Agreement.

 

	 	6.4.2.	Indemnity.
    The Rights Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith. Subject to Section
    6.6, the Company agrees to indemnify the Rights Agent and save it harmless against any and all liabilities, including judgments,
    costs and reasonable counsel fees, for anything done or omitted by the Rights Agent in the execution of this Agreement except as
    a result of the Rights Agent’s gross negligence, willful misconduct, or bad faith.

 

    	 

    	 

    

 

	 	6.4.3.	Exclusions.
    The Rights Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
    of any Right (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or
    condition contained in this Agreement or in any Right; nor shall it by any act hereunder be deemed to make any representation or
    warranty as to the authorization or reservation of any Shares to be issued pursuant to this Agreement or any Right or as to whether
    any Shares will, when issued, be valid and fully paid and nonassessable.

 

	 	6.5.	Acceptance
    of Agency. The Rights Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
    and conditions herein set forth.

 

	 	6.6.	Waiver.
    The Rights Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”)
    in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the
    date hereof, by and between the Company and the Rights Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement,
    payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

	7.	Miscellaneous
    Provisions.

 

	 	7.1.	Successors.
    All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure
    to the benefit of their respective successors and assigns.

 

	 	7.2.	Notices.
    Any notice, statement or demand authorized by this Agreement to be given or made by the Rights Agent or by the holder of any Right
    to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail
    or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed
    in writing by the Company with the Rights Agent), as follows:

 

AlphaTime
Acquisition Corp.

500
5th Avenue, Suite 938

New York, NY 10110

Tel:
(347) 627-0058

 

and

 

Winston
& Strawn LLP

800
Capitol Street, Suite 2400

Houston,
Texas 77002

Attn:
Michael J. Blankenship, Esq.

Email:
MBlankenship@winston.com

 

    	 

    	 

    

 

and

American
Stock Transfer & Trust Company

6201
12th Avenue

Brooklyn,
New York 10004

Attn:
Michelle McLean

Email: Mmclean@astfinancial.com 

 

and

 

Chardan
Capital Markets LLC

17
State Street, 21st Floor

New
York, NY 10004

Attn:
Elliot Gnedy

Email: EGnedy@Chardan.com 

 

and

 

Greenberg
Traurig, LLP

1750
Tysons Boulevard, Suite 1000

McLean,
Virginia 22102

Attn:
Jason T. Simon

Simonj@GTlaw.com

 

	 	7.3.	Applicable
    Law. The validity, interpretation, and performance of this Agreement and of the Rights shall be governed in all respects by the laws
    of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive
    laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating
    in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court
    for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company
    hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process
    or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt
    requested, postage prepaid, addressed to it at the address set forth in Section 7.2 hereof. Such mailing shall be deemed personal
    service and shall be legal and binding upon the Company in any action, proceeding or claim.

 

	 	7.4.	Persons
    Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions
    hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and
    the registered holders of the Rights and, for the purposes of Sections 3.1, 3.2, 7.4 and 7.8 hereof, the Representative, any right,
    remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. the
    Representative shall be deemed to be a third-party beneficiary of this Agreement with respect to Sections 3.1, 3.2, 7.4 and 7.8 hereof.
    All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive
    benefit of the parties hereto (and the Representative with respect to Sections 3.1, 3.2, 7.4 and 7.8 hereof) and their successors
    and assigns and of the registered holders of the Rights.

 

    	 

    	 

    

 

	 	7.5.	Examination
    of this Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Rights Agent in the Borough
    of Manhattan, City and State of New York, for inspection by the registered holder of any Right. The Rights Agent may require any
    such holder to submit his, her or its Right for inspection by it.

 

	 	7.6.	Counterparts.
    This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
    be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

	 	7.7.	Effect
    of Headings. The Section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
    thereof.

 

	 	7.8.	Amendments.
    This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of curing any ambiguity,
    or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with
    respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties
    deem shall not adversely affect the interest of the registered holders. All other modifications or amendments shall require the written
    consent or vote of the registered holders of a majority of the then outstanding Rights. The provisions of this Section 7.8 may not
    be modified, amended or deleted without the prior written consent of the Representative.

 

	 	7.9.	Severability.
    This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect
    the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid
    or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as
    similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Signature
Page Follows]

 

    	 

    	 

    

 

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	AMERICAN STOCK TRANSFER & TRUST COMPANY, as Rights Agent
	 	 	 
	 	By:	 
	 	Name:
    	 
	 	Title:	 
	 	 	 
	 	ALPHATIME ACQUISITION CORP
	 	 	 
	 	By:	 
	 	Name:	Dajiang
    Guo
	 	Title:	Chief
    Executive Officer

 

[Signature
Page to Rights Agreement- AlphaTime Acquisition Corp]

 

    	 

    	 

    

 

EXHIBIT
A

Form
of Right

 

    	 

    	 

    

 

	NUMBER
    	SPECIMEN
    RIGHT CERTIFICATE

 

ALPHATIME
ACQUISITION CORP

INCORPORATED
UNDER THE LAWS OF THE CAYMAN ISLANDS

RIGHT

 

SEE
REVERSE FOR

CERTAIN
DEFINITIONS

 

CUSIP
[●]

 

THIS
CERTIFIES THAT, for value received

 

is
the registered holder of a right or rights (the “Right”) to automatically receive one-tenth of one ordinary
share, $0.0001 par value (the “Ordinary Share”), of AlphaTime Acquisition Corp (the “Company”)
for each Right evidenced by this Right Certificate on the Company’s completion of an initial business combination (as defined in
the prospectus relating to the Company’s initial public offering (“Prospectus”)) upon surrender of this
Right Certificate pursuant to the Rights Agreement between the Company and Continental Stock Transfer & Trust Company, as Rights
Agent. In no event will the Company be required to net cash settle any Right.

 

Upon
liquidation of the Company in the event an initial business combination is not consummated during the required period as identified in
the Company’s Amended and Restated Memorandum and Articles of Association, the Right shall expire and be worthless. The holder
of a Right shall have no right or interest of any kind in the Company’s trust account (as defined in the Prospectus).

 

Upon
due presentment for registration of transfer of the Right Certificate at the office or agency of the Rights Agent, a new Right Certificate
or Right Certificates of like tenor and evidencing in the aggregate a like number of Rights shall be issued to the transferee in exchange
for this Right Certificate, without charge except for any applicable tax or other governmental charge. The Company shall not issue fractional
share upon exchange of Rights. The Company reserves the right to deal with any fractional entitlement at the relevant time in any manner
(as provided in the Rights Agreement).

 

The
Company and the Rights Agent may deem and treat the registered holder as the absolute owner of this Right Certificate (notwithstanding
any notation of ownership or other writing hereon made by anyone), for the purpose of any conversion hereof, of any distribution to the
registered holder, and for all other purposes, and neither the Company nor the Rights Agent shall be affected by any notice to the contrary.

 

This
Right does not entitle the registered holder to any of the rights of a shareholder of the Company.

 

Dated:

 

	 	 	 
	CHAIRMAN	 	CHIEF
    FINANCIAL OFFICER

 

	 	 	 
	Continental
    Stock Transfer & Trust Company, as Rights Agent	 	 

 

    	 

    	 

    

 

The
following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written
out in full according to applicable laws or regulations:

 

	TEN
    COM – as tenants in common	UNIF
    GIFT MIN ACT - __________ Custodian __________
	TEN
    ENT – as tenants by the entireties	(Cust)
    (Minor)
	JT
    TEN – as joint tenants with right of survivorship	under
    Uniform Gifts to Minors
	and
    not as tenants in common	Act
    __________
	 	(State)

 

Additional
Abbreviations may also be used though not in the above list.

	 

AlphaTime
Acquisition Corp

 

The
Company will furnish without charge to each shareholder who so requests the powers, designations, preferences and relative, participating,
optional or other special rights of each class of stock or series thereof of the Company and the qualifications, limitations, or restrictions
of such preferences and/or rights. This certificate and the rights represented thereby are issued and shall be held subject to all the
provisions of the memorandum and articles of association and all amendments thereto and resolutions of the Board of Directors providing
for the issue of Ordinary Shares (copies of which may be obtained from the secretary of the Company), to all of which the holder of this
certificate by acceptance hereof assents.

 

For
value received, ___________________________ hereby sell, assign and transfer unto

 

PLEASE
INSERT SOCIAL SECURITY OR OTHER

 

IDENTIFYING
NUMBER OF ASSIGNEE

 

	 	 

 

(PLEASE
PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)

	 	 
	 	 
	 	 

 

	 	 
	Rights
    represented by the within Certificate, and do hereby irrevocably constitute and appoint	 
	 	 
	Attorney
    to transfer said rights on the books of the within named Company will full power of substitution in the premises.	 

 

    	 

    	 

    

 

Dated
_____________________

 

	 	Notice:	The
    signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without
    alteration or enlargement or any change whatever.

Signature(s)
Guaranteed:

	 	 
	THE
    SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT
    UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).	 

 

The
holder of this certificate shall have no right or interest of any kind in or to the funds held in the Company’s trust account (as
defined in the Prospectus).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]